Skip to main content
FDA Shortage Check

Is Amidate (Etomidate Injection) in shortage?

Label: plusbeauxjours · shortage label · not a prescription, not a pharmacy, not FDA

IN SHORTAGE

Amidate: in shortage (FDA, Oct 24)

Injections (vials)
A generic injection, not your medicine. We draw dosage forms, not products, and never pills you could match to yours.
  • Reason: “Demand increase for the drug”. FDA shortage reason (FDASIA), reported by the manufacturer
  • Reason: “Other”. FDA shortage reason (FDASIA), reported by the manufacturer
  • Estimate: “Estimated Recovery: December 2026”. Manufacturer’s estimate, Hospira, Inc., a Pfizer Company, Oct 21, 2026
DRUG
Amidate
FDA LISTING
FORM
injection
STATUS
Currently in Shortage
FIRST POSTED
Oct 5, 2022
LAST FDA UPDATE
Oct 21, 2026
AS OF
Oct 24, 2026
SOURCE

FDA lists 18 presentations: 5 unavailable · 0 limited · 13 available.

FDA Drug Shortages checked Oct 24, 2026, 21:05 ET · FDA updates daily · manufacturer-reported

Information from FDA’s drug shortage list, reported by manufacturers. Not medical advice. Don’t stop, change or ration a medicine without talking to your prescriber or pharmacist.

FDA's listing, word for word: Etomidate Injection. 18 presentations from 6 makers.

Check your own medication, form and strength

What to ask at the counter

  1. Is this a supply problem at this pharmacy, or everywhere? Could another pharmacy have it? FDA consumer FAQ (opens in a new tab)
  2. Is my strength or the maker you stock affected? FDA list, by presentation
  3. Is there an alternative to this medicine I should ask my prescriber about? FDA consumer FAQ (opens in a new tab)
  4. When should I check back, or can you order it?

FDA: “talk with your health care provider or pharmacist for other treatment options during the shortage.” FDA Drug Shortages page (opens in a new tab)

This listing on FDA ↗ (opens in a new tab)Report a shortage to FDA: drugshortages@fda.hhs.gov

Every presentation FDA lists, by maker

Availability is FDA's text for each package, as the manufacturer reported it. Makers with unavailable or limited packages come first.

Eugia US LLC2 presentations · 2 unavailable

Contact (FDA's listing): 888-238-7880

  • 20 mg/10 mL

    Etomidate, Injection, 20 mg/10 mL (NDC 55150-221-10)

    On backorder. Recovery: TBD. Check wholesalers for inventory

    NDC 55150-221-10Reverified

    Unavailable

  • 40 mg/20 mL

    Etomidate, Injection, 40 mg/20 mL (NDC 55150-222-20)

    On backorder. Recovery: TBD. Check wholesalers for inventory

    NDC 55150-222-20Reverified

    Unavailable

Hospira, Inc., a Pfizer Company2 presentations · 2 unavailable

Contact (FDA's listing): 844-646-4398

  • 2 mg/1 mL

    Amidate, Injection, 2 mg/1 mL (NDC 0409-6695-01)

    Next Delivery: November 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay

    NDC 0409-6695-01Revised

    Unavailable

  • 2 mg/mL

    Amidate, Injection, 2 mg/mL (NDC 0409-6695-02)

    Next Delivery: November 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay

    NDC 0409-6695-02Revised

    Unavailable

Mylan Institutional, a Viatris Company2 presentations · 1 unavailable · 1 available or not stated

Contact (FDA's listing): 800-796-9526

  • 2 mg/1 mL

    Etomidate, Injection, 2 mg/1 mL (NDC 67457-902-10)

    Estimated recovery: November 2026

    NDC 67457-902-10Reverified

    Unavailable

  • 2 mg/1 mL

    Etomidate, Injection, 2 mg/1 mL (NDC 67457-903-20)

    NDC 67457-903-20Reverified

    Available

Caplin Steriles, Ltd.4 presentations · 4 available or not stated

Contact (FDA's listing): 908-803-2586

  • 2 mg/mL

    Etomidate, Injection, 2 mg/mL (NDC 72485-508-10)

    Check wholesalers for inventory; Marketed by Armas Pharmaceuticals, Inc. 908-803-2586

    NDC 72485-508-10Revised

    Available

  • 2 mg/mL

    Etomidate, Injection, 2 mg/mL (NDC 72485-509-10)

    Check wholesalers for inventory; Marketed by Armas Pharmaceuticals, Inc. 908-803-2586

    NDC 72485-509-10Revised

    Available

  • 2mg/1 mL

    Etomidate, Injection, 2mg/1 mL (NDC 65219-445-10)

    Check wholesalers for inventory; Marketed by Fresenius Kabi

    NDC 65219-445-10Revised

    Available

  • 2mg/mL

    Etomidate, Injection, 2mg/mL (NDC 65219-447-20)

    Check wholesalers for inventory; Marketed by Fresenius Kabi

    NDC 65219-447-20Revised

    Available

Gland Pharma Limited2 presentations · 2 available or not stated

Contact (FDA's listing): 833-291-9645

  • 2 mg/1 mL

    Etomidate, Injection, 2 mg/1 mL (NDC 72266-146-10)

    Distributed by Fosun Pharma USA, Inc.. To order, contact: 833-291-9645.

    NDC 72266-146-10Reverified

    Available

  • 2 mg/1 mL

    Etomidate, Injection, 2 mg/1 mL (NDC 72266-147-10)

    Distributed by Fosun Pharma USA, Inc.. To order, contact: 833-291-9645.

    NDC 72266-147-10Reverified

    Available

Hikma Pharmaceuticals USA, Inc.6 presentations · 6 available or not stated

Contact (FDA's listing): 800-631-2174

  • 2 mg/1 mL

    Etomidate, Injection, 2 mg/1 mL (NDC 0143-9310-10)

    Novaplus label

    NDC 0143-9310-10Reverified

    Available

  • 2 mg/1 mL

    Etomidate, Injection, 2 mg/1 mL (NDC 0143-9311-10)

    Novaplus label

    NDC 0143-9311-10Reverified

    Available

  • 2 mg/1 mL

    Etomidate, Injection, 2 mg/1 mL (NDC 0143-9506-10)

    Additional product will be made available as it is released.

    NDC 0143-9506-10Reverified

    Available

  • 2 mg/1 mL

    Etomidate, Injection, 2 mg/1 mL (NDC 0143-9507-10)

    Additional product will be made available as it is released.

    NDC 0143-9507-10Reverified

    Available

  • 2 mg/1 mL

    Etomidate, Injection, 2 mg/1 mL (NDC 72572-160-10)

    Distributed by Civica

    NDC 72572-160-10Reverified

    Available

  • 2 mg/1 mL

    Etomidate, Injection, 2 mg/1 mL (NDC 72572-161-10)

    Distributed by Civica

    NDC 72572-161-10Reverified

    Available

What the manufacturers told FDA

  • Eugia US LLC · ‘On backorder. Recovery: TBD. Check wholesalers for inventory’ · updated Oct 2026
  • Hospira, Inc., a Pfizer Company · ‘Next Delivery: November 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay’ · updated Oct 2026
  • Mylan Institutional, a Viatris Company · ‘Estimated recovery: November 2026’ · updated Oct 2026

More on FDA ↗ (opens in a new tab)

Reason for the shortage (FDASIA)

  • Demand increase for the drug
  • Other

As reported by the manufacturer under the Food and Drug Administration Safety and Innovation Act.

Alternatives

FDA lists none: “Providing a list of alternative drug products for a drug in shortage is part of the ‘practice of medicine.’ FDA does not regulate the practice of medicine.” Your prescriber or pharmacist can talk through options with you. ASHP also tracks shortages and suggested alternatives (different criteria) ↗ (opens in a new tab)

Questions

Is Amidate in shortage?
Yes. As of Oct 24, 2026, FDA lists Etomidate Injection as currently in shortage: 18 presentations, 5 unavailable and 0 limited.
When will the Amidate shortage end?
FDA gives no end date. 3 presentations carry a manufacturer’s own estimate, quoted on this page with its date.
Does FDA list alternatives to Amidate?
No. FDA calls a list of alternatives part of the ‘practice of medicine’. Ask your pharmacist or prescriber.